Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning
Row Comes Ahead Of Expected CHMP Decision
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
You may also be interested in...
Celltrion continues to eye further markets for its CT-P59 regdanvimab monoclonal antibody treatment for COVID-19, especially in the EU, after winning final approval from the Korean Ministry of Food and Drug Safety.
Helped by government support for the development of COVID-19 drugs and vaccines, Celltrion’s monoclonal antibody becomes the first therapeutic for the disease to be officially approved in South Korea.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.